Publication Effectivity of Uniform Multidrug Therapy on the Success of Paucibacillary and Multibacillary Leprosy Treatment Susanto PM, Esti PK, Komarasari E. Nepal Journals Online (JOL). Nepal Journal of Dermatology, Venereology & Leprology. 2022; 20 (2) : 16-23. Download PDF
Publication Drug Delivery Systems on Leprosy Therapy: Moving Towards Eradication? Chaves L, Patriota Y, Soares-Sobrinho J, et al. Pharmaceutics. 2020; Download PDF
Publication Levels of disability and relapse in Bangladeshi MB leprosy cases, 10 years after treatment with 6m MB-MDT Butlin C, Aung K, Withington S, et al. Leprosy review. 2019; 90 (4) : 388–398. Download PDF
Publication Unanswered questions on the safety of MDT-U - Reply. Penna GO, Gonçalves H, Pontes MAA. Anais brasileiros de dermatologia. 2019; 94 (4) : 500. Download PDF
Publication Unanswered questions on the safety of MDT-U. Barve A. Anais brasileiros de dermatologia. 2019; 94 (4) : 499. Download PDF
Publication Clinical trial for uniform multidrug therapy for leprosy patients in Brazil (U-MDT/CT-BR): adverse effects approach. Cruz R, Bührer-Sékula S, Penna GO, et al. Anais brasileiros de dermatologia. 2018; 93 (3) : 377-384. Download PDF
Publication Mycobacterium leprae- specific antibodies in multibacillary leprosy patients decrease during and after treatment with either the regular 12 doses multi-drug therapy (MDT) or the uniform 6 doses MDT. Hungria EM, Bührer-Sékula S, Oliveira RM, et al. Frontiers in immunology. 2018; Download PDF
Publication Clinical trial for uniform multidrug therapy for leprosy patients in Brazil (U-MDT/CT-BR): adverse effects approach. Cruz RCS, Bührer-Sékula S, Penna GO, et al. Anais brasileiros de dermatologia. 2018; 93 (3) : 377-384. Download PDF
Publication Specific antibodies in multibacillary leprosy patients decrease during and after treatment with either the regular 12 doses multidrug therapy (MDT) or the uniform 6 doses MDT. Hungria EM, Bührer-Sékula S, Oliveira RM, et al. Frontiers in immunology. 2018; Download PDF
Publication WHO Guidelines for the diagnosis, treatment and prevention of leprosy World Health Organization , Regional Office for South-East Asia. . World Health Organization. 2018; Download PDF
Publication Leprosy: current situation, clinical and laboratory aspects, treatment history and perspective of the uniform multidrug therapy for all patients. Cruz RCS, Bührer-Sékula S, Penna ML, et al. Anais brasileiros de dermatologia. 2017; 92 (6) : 761-773. Download PDF
Publication Uniform multidrug therapy for leprosy patients in Brazil (U-MDT/CT-BR): Results of an open label, randomized and controlled clinical trial, among multibacillary patients. Penna GO, Bührer-Sékula S, Kerr LRS, et al. PLoS neglected tropical diseases. 2017; 11 (7) : e0005725. Download PDF
Publication Leprosy reactions: The predictive value of Mycobacterium leprae-specific serology evaluated in a Brazilian cohort of leprosy patients (U-MDT/CT-BR). Hungria EM, Bührer-Sékula S, Oliveira RM, et al. PLoS neglected tropical diseases. 2017; 11 (2) : e0005396. Download PDF
Publication Whole genome sequencing distinguishes between relapse and reinfection in recurrent leprosy cases. Stefani M, Avanzi C, Bührer-Sékula S, et al. PLoS neglected tropical diseases. 2017; 11 (6) : e0005598. Download PDF
Publication Correlates of Defaulting from MDT among Leprosy Patients. Raju M S, Elkana M, Failbus P, et al. Indian journal of leprosy. 2016; 87 (4) : 241-248.
Publication Uniform multidrug therapy for leprosy - time for a rethink? Saunderson P. The Indian journal of medical research. 2016; 144 (4) : 499-501. Download PDF
Publication Results of eight years follow up among multibacillary patients treated with Uniform Multidrug Therapy in China Liangbin Y, Jianping S, Meiwen Y, et al. Leprosy review. 2016; 87 (30) : 314–321. Download PDF
Publication International open trial of uniform multidrug therapy regimen for leprosy patients: Findings & implications for national leprosy programmes. Manickam P, Mehendale SM, Nagaraju B, et al. The Indian journal of medical research. 2016; 144 (4) : 525-535. Download PDF
Publication Can baseline ML Flow test results predict leprosy reactions? An investigation in a cohort of patients enrolled in the uniform multidrug therapy clinical trial for leprosy patients in Brazil. Hungria EM, Oliveira RM, Penna GO, et al. Infectious diseases of poverty. 2016; 5 (1) : 110. Download PDF